PINK1 and neuroblastoma: Overall, our data is consistent with in vitro research findings from our research group, which showed that pharmacologically elevating downstream PKA activity can compensate for mitochondrial dysfunction and reverse degeneration in PINK1-deficient neuroblastoma SH-SY5Y cells and primary cortical neurons [41,44].